Cargando...

B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them.

The clinical efficacy and safety of interleukin-6 (IL-6) receptor blockade have been well studied, but the data on the impact of therapeutic inhibition of IL-6 on B cells are scarce and contradictory. Preliminary reports have shown that B cell function and a humoral immune response may be modulated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. V. Gerasimova, T. V. Popkova, A. P. Aleksankin, A. V. Martynova, E. L. Nasonov
Formato: Artigo
Lenguaje:Russo
Publicado: IMA-PRESS LLC 2019-01-01
Colección:Научно-практическая ревматология
Materias:
Acceso en línea:https://rsp.mediar-press.net/rsp/article/view/2650
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!